title: Infliximab, azathioprine, or combination therapy for Crohn's disease.
authors.forename: Cesare
authors.initials: C
authors.lastname: Ruffolo
authors.forename: Marco
authors.initials: M
authors.lastname: Scarpa
authors.forename: Nicolò
authors.initials: N
authors.lastname: Bassi
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000069285:Infliximab; D009369:Neoplasms / Q000139:chemically induced
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine